Fixed Income Market Overview

U.S. Treasury yields rose on Thursday after weekly jobless claims came in lower than expected, easing fears of a weakening labor market suggested by July’s payroll report. The 10-year Treasury  yield increased by 2 basis points to 3.992%, nearing last week’s levels before the disappointing jobs data. The 2-year note yield rose by nearly 5 basis points to 4.048%. Initial unemployment claims were 233,000, below the expected 240,000, indicating the labor market remains robust. This report contributed to market stability after concerns of an economic slowdown earlier in the  week.

icon-oneWeekly jobless claims fall to 233,000, less than expected, in a positive sign for labor market.
icon-twoApple could charge up to $20 for some Apple Intelligence AI features, analysts say.
icon-threeMeta is selling $10.5B of investment-grade bonds in its largest-ever debt sale.
icon-fourJPMorgan raises 2024 recession odds to 35%.
icon-fiveOil prices steady after two days of gains as market waits for Iran strike.

 

Major Indicies

Symbol Price Change %Change
DJIA 38,763.45 683.04 1.76%↑
NASDAQ 17,867.37 546.45 3.06%↑
S&P 500 5,199.50 119.81 2.30%↑
FTSE 100 8,166.88 -21.91 -0.27%↓
SX5E 4,668.06 0.68 0.01%↑
NIKKEI 35,089.62 -258.47 -0.73%↓
HSI 16,877.86 13.97 0.08%↑
VIX 27.85 -4.06 -14.58%↓

Bonds

Name Yeild CHG
US 10-YR 3.99% 0.04
US 30-YR 4.28% 0.03
US 5-YR 3.83% 0.06
JPN 10-YR 0.85% -0.04
UK 10-YR 3.75% 0.04

Futures & Commodities

Name Last Change %Change
WTI CRUDE 76.19 0.96 1.28%↑
NAT GAS 2.12 0.01 0.71%↑
GOLD 2,427.53 44.61 1.87%↑
SILVER 27.54 0.93 3.51%↑
COPPER 3.95 0.00 0.18%↑
Data and Content as of Previous Closing Day. Source: MarketWatch

 

Equity Market Overview

Eli Lily

Eli Lilly reported exceptional second-quarter earnings, driven by soaring demand for its diabetes drug Mounjaro and weight loss injection Zepbound. The company raised its full-year revenue  outlook by $3 billion, now expecting $45.4 billion to $46.6 billion. Quarterly revenue surged 36% year-over-year to $11.3 billion, far exceeding expectations, with Mounjaro and Zepbound contributing $3.09 billion and $1.24 billion, respectively. Despite ongoing supply challenges, Eli Lilly is ramping up production to meet demand. Shares rose over 7%, continuing a  strong year after a 60% increase in 2023 due to high investor interest.

Siemens

Siemens reported better-than-expected quarterly operating profit of €3 billion, an 11% increase from the previous year, and confirmed its full-year outlook. Despite strong performance in electrification and industrial software, comparable orders declined by 15%, primarily due to a sharp drop in the mobility sector. CEO Roland Busch highlighted strong demand in key areas but  noted challenges in the automation business. Siemens expects full-year revenue growth at the lower end of its 4%-8% forecast due to market difficulties. The company also emphasized its ongoing  integration of artificial intelligence to enhance its portfolio.

Under Armour

Under Armour reported better-than expected fiscal first-quarter results despite sales declines across its business, sending its stock up 17%. The company posted a small profit of $4 million, or 1 cent per share, beating Wall Street’s expectations of an 8-cent loss, though sales dropped 10% year-over-year to $1.18 billion. Despite these results, Under Armour settled a costly securities lawsuit for $434 million and revised its fiscal 2025 outlook to a projected loss. The company is undergoing restructuring to regain relevance and boost profitability, including reducing discounts,  laying off workers, and positioning itself as a premium brand.

Latest Update: Aug 09, 2024